protelos
mediline ltd. - strontium ranelate 2 g - granules for oral suspension - strontium ranelate - treatment of postmenopausal osteoporosis to reduce the risk of vertebral and hip fractures.
protelos granules for oral suspension 2 g
wael pharmacy - strontium ranelate - granules for oral suspension - 2
protaxos (granules for oral suspension)
servier malaysia sdn bhd - strontium ranelate -
metastron strontium chloride sr-89 injection powder lyophilized for solution
medi-physics inc. - strontium chloride sr-89 (unii: 5r78837d4a) (strontium cation sr-89 - unii:06a33308kh) - strontium cation sr-89 1 mci in 1 ml
esomeprazole strontium- esomeprazole strontium capsule, delayed release
parapro llc - esomeprazole strontium (unii: c5n25h3803) (esomeprazole - unii:n3pa6559ft) - esomeprazole 24.65 mg - 1.1 treatment of gastroesophageal reflux disease (gerd) in adults healing of erosive esophagitis esomeprazole strontium is indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. for those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of esomeprazole strontium may be considered. maintenance of healing of erosive esophagitis esomeprazole strontium is indicated to maintain symptom resolution and healing of erosive esophagitis. controlled studies do not extend beyond 6 months. symptomatic gastroesophageal reflux disease esomeprazole strontium is indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with gerd in adults. 1.2 risk reduction of nsaid-associated gastric ulcer in adults esomeprazole strontium is indicated for the reduction in the occurrence of gastric ulcers associated with continuous nsaid therapy in patients at risk for devel
esomeprazole strontium capsule, delayed release
r2 pharma, llc - esomeprazole strontium (unii: c5n25h3803) (esomeprazole - unii:n3pa6559ft) - esomeprazole 40 mg - 1.1 treatment of gastroesophageal reflux disease (gerd) in adults healing of erosive esophagitis esomeprazole strontium is indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. for those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of esomeprazole strontium may be considered. maintenance of healing of erosive esophagitis esomeprazole strontium is indicated to maintain symptom resolution and healing of erosive esophagitis. controlled studies do not extend beyond 6 months. symptomatic gastroesophageal reflux disease esomeprazole strontium is indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with gerd in adults. 1.2 risk reduction of nsaid-associated gastric ulcer in adults esomeprazole strontium is indicated for the reduction in the occurrence of gastric ulcers associated with continuous nsaid therapy in patients at risk for devel
strontium bromatum pellet
rxhomeo private limited d.b.a. rxhomeo, inc - strontium bromide (unii: 1ng558x5vj) (strontium cation - unii:37077s2c93) - nervous dyspepsia condition listed above or as directed by the physician
strontium muriaticum pellet
hahnemann laboratories, inc. - strontium chloride hexahydrate (unii: o09usb7z44) (strontium cation - unii:37077s2c93) -
strontium metallicum pellet
hahnemann laboratories, inc. - strontium (unii: yzs2rpe8le) (strontium - unii:yzs2rpe8le) -
strontium carbonicum- strontium carbonate pellet
boiron - strontium carbonate (unii: 41ypu4mmca) (strontium cation - unii:37077s2c93) - head congestion improved by heat* stop use and ask a doctor if symptoms persist for more than 3 days or worsen